| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.59 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.18 | 0.4 |